AI drug discovery

Alphabet’s AI drug discovery platform Isomorphic Labs raises $600M from Thrive

Biotech & Health /

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised external capital for the first time. The $600 million round was led by Thrive Capital, with participation from GV and existing investor Alphabet, Google’s parent, it said.     The funding will accelerate further development of Isomorphic’s AI drug […]

Alphabet’s AI drug discovery platform Isomorphic Labs raises $600M from Thrive Read More »

Lindus Health raises $55M to ‘fix the broken clinical trial industry’

Fundraising /

A four-year-old London startup backed by Peter Thiel has raised a $55 million Series B round as it sets about “fixing the broken clinical trial industry.” The announcement comes as artificial intelligence is shaping up to revolutionize drug discovery and development, in turn spurring demand for a streamlined clinical trial process to help get new

Lindus Health raises $55M to ‘fix the broken clinical trial industry’ Read More »

Heart disease is the world’s biggest killer — this Cambridge Uni spinout is using AI to find new treatments

Biotech & Health /

While artificial intelligence (AI) promises to transform all manner of industries, the biggest game-changing breakthroughs in this new era of data-infused machine intelligence arguably lies in the field of drug discovery. By analyzing vast amounts of biological data, AI can help researchers predict how different chemical compounds will interact with specific targets in the body,

Heart disease is the world’s biggest killer — this Cambridge Uni spinout is using AI to find new treatments Read More »